We consider this space to be better than anything offered in the Boston ecosystem. We can’t be a biotech without lab space. It was a remarkable space for us. We’ve done everything on about 30-40% of typical funding…(we are) fast and lean and light. By far the nicest we’ve seen and it’s in a price point that is remarkably affordable. The whole ecosystem really is comprised of a number of heroic people.

David Hysong
Founder & CEO, SHEPHERD Therapeutics

I have worked at ABI-Lab for over a year and it is a great place for startups! The combination of shared equipment, collaborative atmosphere and extremely competitive leasing make this a great location for your biotech company!

Scott Sauer
Head of Preclinical Discovery, at Vuja De Sciences

In the end it was a very simple choice for us. We chose ABI-LAB because of location, but also because it had all the utilities, it was set up for research. We were literally doing experiments the day after our first box moved into the lab. And it’s allowed us to focus on what we do. If I had to set up all the equipment, if I had a quarter million dollars…it would take me 3 months. Most companies go bankrupt. Here I know what my costs are going to be. This is going to be the difference between making it or not. That’s what it’s enabled. Keep on working hard and fast.

W. Richard Light, PhD
Chief Scientific Officer, VirTech Bio

We were among the first companies to join ABI-LAB at the beginning of 2016 and have been very happy with our decision. As we looked for lab space west of Boston, it became clear that ABI-LAB would be a great fit for us due to the location, space and cost. The shared equipment in the two buildings has saved us money and time by allowing us access to centrifuges, a plate reader, a nanodrop, -80 freezer space and so on. The management of the building is very responsive to our requests and worked with us to obtain more space to expand when COVID 19 disrupted our work environment. They have provided a safe, friendly atmosphere to work and we plan to remain at ABI-LAB for the foreseeable future.

Paul Rennert
Co-founder, Aleta Biotherapeutics

ABI-LAB presented an opportunity. What we were looking for was a space where we continue to have a private suite and can add more people as we are growing but still have access to a shared lab. ABI-LAB presented the right opportunity.

Edwin Tan
Director, GO Therapeutics

ABI-LAB has been very flexible for all six of our biotech companies, accommodating to our stages and phases since 2016. SOLA Biosciences was the first resident in ABI-LAB. It is a place where we can focus on projects as well as collaborate with other scientists and entrepreneurs. The owners, Raphael and Gary, have been very supportive to us. They are more than just the owners, but they are fellow colleagues working with us to achieve our goals.

Keizo Koya, PhD
CEO, Strategia Holdings and SOLA Biosciences